| 摘要 |
<p>The invention relates to novel compounds having the general formula:(1) wherein X is O or S which are useful as selective ER-β ligands in the treatment or prophylaxis of Alzheimer's disease, anxiety disorders, depressive disorders, osteoporosis, cardiovasculardisease, rheumatoid arthritis or prostate cancer.</p> |
